Barinthus Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BRNS and other ETFs, options, and stocks.About BRNS
Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs.
CEOWilliam Enright
CEOWilliam Enright
Employees105
Employees105
HeadquartersDidcot, Oxfordshire
HeadquartersDidcot, Oxfordshire
Founded2021
Founded2021
Employees105
Employees105
BRNS Key Statistics
Market cap29.75M
Market cap29.75M
Price-Earnings ratio-0.38
Price-Earnings ratio-0.38
Dividend yield—
Dividend yield—
Average volume44.26K
Average volume44.26K
High today$0.7374
High today$0.7374
Low today$0.7116
Low today$0.7116
Open price$0.7122
Open price$0.7122
Volume11.74K
Volume11.74K
52 Week high$2.92
52 Week high$2.92
52 Week low$0.64
52 Week low$0.64
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.